Drug Repositioning for Gynecologic Tumors: A New Therapeutic Strategy for Cancer
The goals of drug repositioning are to find a new pharmacological effect of a drug for which human safety and pharmacokinetics are established and to expand the therapeutic range of the drug to another disease. Such drug discovery can be performed at low cost and in the short term based on the resul...
Main Authors: | Kouji Banno, Miho Iida, Megumi Yanokura, Haruko Irie, Kenta Masuda, Yusuke Kobayashi, Eiichiro Tominaga, Daisuke Aoki |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2015-01-01
|
Series: | The Scientific World Journal |
Online Access: | http://dx.doi.org/10.1155/2015/341362 |
Similar Items
-
MicroRNA in Cervical Cancer: OncomiRs and Tumor Suppressor miRs in Diagnosis and Treatment
by: Kouji Banno, et al.
Published: (2014-01-01) -
Profiling of the Causative Bacteria in Infected Lymphocysts after Lymphadenectomy for Gynecologic Cancer by Pyrosequencing the 16S Ribosomal RNA Gene Using Next-Generation Sequencing Technology
by: Yuya Nogami, et al.
Published: (2019-01-01) -
Current Status and Prospects of Immunotherapy for Gynecologic Melanoma
by: Mayuka Anko, et al.
Published: (2021-05-01) -
Application of MicroRNA in Diagnosis and Treatment of Ovarian Cancer
by: Kouji Banno, et al.
Published: (2014-01-01) -
Methylation Analysis of DNA Mismatch Repair Genes Using DNA Derived from the Peripheral Blood of Patients with Endometrial Cancer: Epimutation in Endometrial Carcinogenesis
by: Takashi Takeda, et al.
Published: (2016-10-01)